CN102627644B - 一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法 - Google Patents

一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法 Download PDF

Info

Publication number
CN102627644B
CN102627644B CN201210103893.3A CN201210103893A CN102627644B CN 102627644 B CN102627644 B CN 102627644B CN 201210103893 A CN201210103893 A CN 201210103893A CN 102627644 B CN102627644 B CN 102627644B
Authority
CN
China
Prior art keywords
compound
molar ratio
solvent
ratio
catalyst
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210103893.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN102627644A (zh
Inventor
洪浩
詹姆斯·盖吉
陈朝勇
卢江平
周炎
刘双勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asymchem Laboratories Fuxin Co Ltd
Asymchem Laboratories Tianjin Co Ltd
Asymchem Laboratories Jilin Co Ltd
Asymchem Life Science Tianjin Co Ltd
Tianjin Asymchem Pharmaceutical Co Ltd
Original Assignee
Asymchem Laboratories Fuxin Co Ltd
Asymchem Laboratories Tianjin Co Ltd
Asymchem Laboratories Jilin Co Ltd
Asymchem Life Science Tianjin Co Ltd
Tianjin Asymchem Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asymchem Laboratories Fuxin Co Ltd, Asymchem Laboratories Tianjin Co Ltd, Asymchem Laboratories Jilin Co Ltd, Asymchem Life Science Tianjin Co Ltd, Tianjin Asymchem Pharmaceutical Co Ltd filed Critical Asymchem Laboratories Fuxin Co Ltd
Priority to CN201210103893.3A priority Critical patent/CN102627644B/zh
Publication of CN102627644A publication Critical patent/CN102627644A/zh
Priority to HUE12874350A priority patent/HUE033184T2/en
Priority to PL12874350T priority patent/PL2837630T3/pl
Priority to EP12874350.7A priority patent/EP2837630B1/de
Priority to PCT/CN2012/087737 priority patent/WO2013152609A1/zh
Priority to RS20170076A priority patent/RS55629B1/sr
Priority to US14/391,712 priority patent/US9365573B2/en
Priority to SI201230865A priority patent/SI2837630T1/sl
Priority to DK12874350.7T priority patent/DK2837630T3/en
Priority to PT128743507T priority patent/PT2837630T/pt
Priority to LTEP12874350.7T priority patent/LT2837630T/lt
Priority to ES12874350.7T priority patent/ES2613453T3/es
Application granted granted Critical
Publication of CN102627644B publication Critical patent/CN102627644B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/12Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with hydrogen peroxide or inorganic peroxides or peracids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/14Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic peracids, or salts, anhydrides or esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201210103893.3A 2012-04-10 2012-04-10 一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法 Active CN102627644B (zh)

Priority Applications (12)

Application Number Priority Date Filing Date Title
CN201210103893.3A CN102627644B (zh) 2012-04-10 2012-04-10 一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法
US14/391,712 US9365573B2 (en) 2012-04-10 2012-12-27 Method for synthesizing sapropterin dihydrochloride
DK12874350.7T DK2837630T3 (en) 2012-04-10 2012-12-27 Process for synthesizing sapropterine dihydrochloride
EP12874350.7A EP2837630B1 (de) 2012-04-10 2012-12-27 Verfahren zur synthese von sapropterindihydrochlorid
PCT/CN2012/087737 WO2013152609A1 (zh) 2012-04-10 2012-12-27 一种二盐酸沙丙蝶呤的合成方法
RS20170076A RS55629B1 (sr) 2012-04-10 2012-12-27 Postupak za sintezu sapropterin dihidrohlorida
HUE12874350A HUE033184T2 (en) 2012-04-10 2012-12-27 A method for preparing sapropterin dihydrochloride
SI201230865A SI2837630T1 (sl) 2012-04-10 2012-12-27 Postopek za sintetiziranje sapropterin dihidroklorida
PL12874350T PL2837630T3 (pl) 2012-04-10 2012-12-27 Sposób syntezy dichlorowodorku sapropteryny
PT128743507T PT2837630T (pt) 2012-04-10 2012-12-27 Método para sintetizar dicloridrato de sapropterina
LTEP12874350.7T LT2837630T (lt) 2012-04-10 2012-12-27 Sapropterino dihidrochlorido sintetinimo būdas
ES12874350.7T ES2613453T3 (es) 2012-04-10 2012-12-27 Método para sintetizar diclorhidrato de sapropterina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210103893.3A CN102627644B (zh) 2012-04-10 2012-04-10 一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法

Publications (2)

Publication Number Publication Date
CN102627644A CN102627644A (zh) 2012-08-08
CN102627644B true CN102627644B (zh) 2014-04-16

Family

ID=46586062

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210103893.3A Active CN102627644B (zh) 2012-04-10 2012-04-10 一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法

Country Status (12)

Country Link
US (1) US9365573B2 (de)
EP (1) EP2837630B1 (de)
CN (1) CN102627644B (de)
DK (1) DK2837630T3 (de)
ES (1) ES2613453T3 (de)
HU (1) HUE033184T2 (de)
LT (1) LT2837630T (de)
PL (1) PL2837630T3 (de)
PT (1) PT2837630T (de)
RS (1) RS55629B1 (de)
SI (1) SI2837630T1 (de)
WO (1) WO2013152609A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102627644B (zh) * 2012-04-10 2014-04-16 凯莱英医药集团(天津)股份有限公司 一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法
CN102633799B (zh) 2012-04-10 2014-06-25 凯莱英医药集团(天津)股份有限公司 一种从消旋体中间体拆分路线合成二盐酸沙丙蝶呤的方法
CN103483170B (zh) * 2013-09-24 2015-02-04 中国科学技术大学 一种拆分手性二酮化合物的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS574990A (en) * 1980-05-09 1982-01-11 Bisukonchiini Matsukusu Polyacylated tetrahydropterin derivative and manufacture
JPS60178887A (ja) * 1984-02-23 1985-09-12 Kanegafuchi Chem Ind Co Ltd 5,6,7,8−テトラヒドロ−l−ビオプテリンの製造法
JPS60204786A (ja) 1984-03-29 1985-10-16 Univ Nagoya (6r)―テトラヒドロビオプテリンの合成法
US4713454A (en) * 1985-01-28 1987-12-15 Shiratori Pharmaceutical Co., Ltd. Preparation process of (6R)-tetrahydro-L-biopterin
DE3853711T2 (de) * 1987-11-30 1996-01-11 Vitamin Kenkyusho Kk Zwischenverbindungen für die Synthese von 5,6,7,8-Tetrahydro-L-erythro-biopterin und seiner Derivate.
JP2882116B2 (ja) 1991-09-13 1999-04-12 日本電気株式会社 ヒートシンク付パッケージ
EP1699793A1 (de) 2003-12-30 2006-09-13 Vasopharm Biotech GmbH 4-amino-7,8-dihydropteridine, pharmazeutische zusammensetzungen, die diese enthalten, und deren verwendung bei der behandlung von krankheiten, die durch eine erhöhte stickoxidkonzentration verursacht werden
US7361759B2 (en) * 2004-12-27 2008-04-22 Shiratori Pharmaceutical Co., Ltd Method for producing L-biopterin
MX2010007452A (es) * 2008-01-07 2010-08-18 Biomarin Pharm Inc Metodo para sintetizar tetrahidrobiopterin.
IT1400964B1 (it) * 2010-06-15 2013-07-05 Dipharma Francis Srl Procedimento per la preparazione di derivati pteridinici
CN102627644B (zh) * 2012-04-10 2014-04-16 凯莱英医药集团(天津)股份有限公司 一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法
CN102633799B (zh) 2012-04-10 2014-06-25 凯莱英医药集团(天津)股份有限公司 一种从消旋体中间体拆分路线合成二盐酸沙丙蝶呤的方法

Also Published As

Publication number Publication date
CN102627644A (zh) 2012-08-08
WO2013152609A1 (zh) 2013-10-17
HUE033184T2 (en) 2017-11-28
PL2837630T3 (pl) 2017-06-30
RS55629B1 (sr) 2017-06-30
US20150105555A1 (en) 2015-04-16
EP2837630A4 (de) 2015-12-02
US9365573B2 (en) 2016-06-14
DK2837630T3 (en) 2017-02-27
PT2837630T (pt) 2017-02-24
ES2613453T3 (es) 2017-05-24
EP2837630B1 (de) 2016-11-23
LT2837630T (lt) 2017-02-10
SI2837630T1 (sl) 2017-03-31
EP2837630A1 (de) 2015-02-18

Similar Documents

Publication Publication Date Title
CN102633799B (zh) 一种从消旋体中间体拆分路线合成二盐酸沙丙蝶呤的方法
CN106117144B (zh) 一种高纯度依达拉奉的合成工艺
CN102627644B (zh) 一种通过直接手性合成方法制备二盐酸沙丙蝶呤的方法
CN111646964B (zh) 一种碱催化的合成2h-吡喃-2-酮衍生物新方法
CN112062767B (zh) 一种卢美哌隆的制备方法及其中间体
CN113735903A (zh) 一种瑞德西韦的合成方法
CN105693735A (zh) 马来酸阿塞那平一种制备方法
CN116396298A (zh) CDK Ligand-1的中间体XII及CDK Ligand-1的制备方法
CN112899321A (zh) 一种劳拉替尼关键中间体制备方法
CN108250195A (zh) 帕利哌酮的新合成方法
CN107673978B (zh) 一种2,2-二氟环烷基甲胺的中间体及其制备方法
CN107216335B (zh) 一种叔丁基1-(羟甲基)-3-氧杂-9-氮杂螺[5.5]十一烷-9-甲酸基酯制法
CN102010355B (zh) (1r,2r)-1-对甲砜基苯基-2-氨基-1,3-丙二醇的合成方法
CN102321045B (zh) 一种制备高吗啉盐酸盐的方法
CN115819382A (zh) 一锅法合成2,5-二甲基-4-羟基-3(2h)-呋喃酮香料的方法
CN104402744A (zh) 一种加巴喷丁的制备方法
CN110804022B (zh) 一种右丙亚胺的制备方法
CN112939849B (zh) 一种(s,s)-2,8-二氮杂双环[4.3.0]壬烷中间体及其制备方法和应用
CN110092726B (zh) 一种Bictegravir中间体的合成方法
CN103339102A (zh) 合成取代的氨基环己酮衍生物的方法
WO2009011551A2 (en) Process for the efficient preparation of 3-hydroxy pyrrolidine and derivatives thereof
CN118666651A (zh) 一种达泊西汀手性中间体的制备方法
CN100556906C (zh) 一种蛋白酶抑制剂重要中间体的制备方法
CN114685509A (zh) 一种瑞德西韦中间体或其盐酸盐的制备方法
CN115976132A (zh) 一种西他列汀及其类似物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant